TY  - CONF

T1  - Combination therapy with gefitinib (ZD1839) and rofecoxib in platinum-pretreated relapsed non-small-cell lung cancer (NSCLC).

JO  - JOURNAL OF CLINICAL ONCOLOGY

PY  - 2004/07/15

AU  - O'Byrne K

AU  - Clarke L

AU  - Dunlop D

AU  - Ranson M

AU  - Danson S

AU  - Botwood N

AU  - Carbone D

ED  - 

VL  - 22

IS  - 14

SP  - 641S

EP  - 641S

Y2  - 2024/09/19

ER  -